View in EDS HTML Full Text PDF Full Text

Complete Pathologic Response to PARP Inhibitor Olaparib in a Patient with Stage IVB Recurrent Endometrioid Endometrial Adenocarcinoma.

Saved in:
Bibliographic Details
Title: Complete Pathologic Response to PARP Inhibitor Olaparib in a Patient with Stage IVB Recurrent Endometrioid Endometrial Adenocarcinoma.
Authors: Senguttuvan, Rosemary Noel1 (AUTHOR) rsenguttuvan@coh.org, Wei, Christina2 (AUTHOR) cwei@coh.org, Raoof, Mustafa1 (AUTHOR) mraoof@coh.org, Dellinger, Thanh H.1 (AUTHOR) tdellinger@coh.org, Wang, Edward Wenge3 (AUTHOR) edwang@coh.org
Source: Journal of Clinical Medicine. Jun2023, Vol. 12 Issue 11, p3839. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20770383
DOI:10.3390/jcm12113839